Global Peptic Ulcer Testing Market Size By Type (Upper Endoscopy, Gastrointestinal Endoscopy), By Application (Hospitals, Laboratories), By Region, And Segment Forecasts, 2023 to 2032

The Global Peptic Ulcer Testing Market was valued at USD 4.1 billion in 2023 and is expected to reach USD 6.9 billion by 2031, growing at a CAGR of 6.2% during the forecast period from 2023 to 2031. The increasing prevalence of Helicobacter pylori infections, rising incidence of gastrointestinal disorders, and growing awareness of early diagnosis are the primary drivers fueling market growth. With advancements in diagnostic technologies and the rising preference for non-invasive testing methods, healthcare providers are increasingly adopting peptic ulcer testing solutions to improve patient outcomes and reduce complications associated with delayed diagnosis.

Drivers

Rising Prevalence of H. pylori Infections

Helicobacter pylori is a key causative agent of peptic ulcers, and its global prevalence continues to be a major concern, particularly in low- and middle-income countries. The demand for reliable diagnostic methods to detect this bacterium is pushing the growth of the market.

Increased Demand for Non-Invasive Testing Methods

The shift toward non-invasive diagnostic procedures like urea breath tests and stool antigen tests is driving market expansion. These methods offer higher patient comfort and compliance, improving the overall diagnostic process.

Technological Advancements in Diagnostic Tools

Innovations such as real-time PCR testing and monoclonal antibody-based assays are enhancing the accuracy and speed of peptic ulcer detection, making them attractive for both hospital laboratories and point-of-care settings.

Restraints

High Cost of Advanced Testing Methods

The initial investment and operational costs of advanced diagnostic equipment can limit their adoption, especially in resource-constrained regions.

Lack of Awareness in Underserved Areas

In many rural and underdeveloped areas, a lack of awareness about the symptoms and long-term complications of peptic ulcers continues to hinder early diagnosis and treatment.

Opportunity

Expansion into Emerging Markets

Emerging economies offer untapped potential due to improving healthcare infrastructure and rising investments in public health initiatives. Increased focus on infectious disease diagnosis presents significant opportunities for peptic ulcer testing providers.

Development of Rapid Point-of-Care Testing Kits

Point-of-care diagnostics for peptic ulcers, especially those that deliver accurate results within minutes, are gaining traction. Their development and distribution can unlock new market avenues, particularly in outpatient and remote care settings.

Market by System Type Insights

Based on system type, the Urea Breath Test segment held the largest market share in 2023. Known for its non-invasiveness and high accuracy in detecting H. pylori infections, the urea breath test is widely adopted in clinical settings. Meanwhile, stool antigen tests are projected to grow rapidly due to their cost-effectiveness and ease of use, especially in low-resource settings.

Market by End-Use Insights

The Hospitals & Clinics segment dominated the market in 2023, accounting for the majority share due to their established diagnostic infrastructure and high patient footfall. However, the diagnostic laboratories segment is expected to witness strong growth, driven by outsourcing trends and the increasing number of specialty labs focusing on gastrointestinal testing.

Market by Regional Insights

North America led the global peptic ulcer testing market in 2023, driven by well-established healthcare systems, greater awareness levels, and early adoption of advanced diagnostics. Asia-Pacific, however, is projected to register the highest CAGR during the forecast period, supported by the large patient base, high H. pylori prevalence, and improving healthcare accessibility in countries like China and India.

Competitive Scenario

Key players in the global peptic ulcer testing market include Abbott Laboratories, Thermo Fisher Scientific, QuidelOrtho Corporation, Bio-Rad Laboratories, Meridian Bioscience, DiaSorin S.p.A., and Sekisui Diagnostics. These companies are focusing on product innovation, strategic collaborations, and geographic expansion to strengthen their competitive position.

In 2023, Abbott launched an advanced H. pylori stool antigen detection kit featuring improved sensitivity for early-stage infections.

In 2024, QuidelOrtho introduced a point-of-care breath test device, offering rapid and reliable detection of peptic ulcers in under 10 minutes.

Meridian Bioscience expanded its diagnostic reagent production facilities in North America to meet rising demand for H. pylori testing.

Scope of Work – Global Peptic Ulcer Testing Market

Report Metric Details

Market Size (2023) USD 4.1 billion

Projected Market Size (2031) USD 6.9 billion

CAGR (2023–2031) 6.2%

Market Segments By System Type, End-Use, Region

Growth Drivers Rising H. pylori prevalence, demand for non-invasive tests, diagnostic innovation

Opportunities Emerging markets, point-of-care test development

Key Market Developments

2023: Abbott Laboratories unveiled its next-gen stool antigen test featuring AI-integrated analysis capabilities to improve diagnostic accuracy.

2024: Bio-Rad Laboratories partnered with a global research institute to develop a rapid PCR-based peptic ulcer detection assay aimed at point-of-care use.

2025: DiaSorin S.p.A. expanded its diagnostic platform with a new H. pylori molecular testing module to support centralized lab workflows.

FAQs

1. What is the current market size of the Global Peptic Ulcer Testing Market?

The market was valued at USD 4.1 billion in 2023.

2. What is the major growth driver of the Global Peptic Ulcer Testing Market?

The primary growth driver is the rising prevalence of H. pylori infections and increasing demand for accurate, non-invasive diagnostic solutions.

3. Which is the largest region during the forecast period in the Global Peptic Ulcer Testing Market?

North America holds the largest share, while Asia-Pacific is projected to witness the fastest growth.

4. Which segment accounted for the largest market share in Global Peptic Ulcer Testing Market?

The Urea Breath Test segment held the largest share by system type in 2023.

5. Who are the key market players in the Global Peptic Ulcer Testing Market?

Major players include Abbott Laboratories, Thermo Fisher Scientific, QuidelOrtho Corporation, Bio-Rad Laboratories, and Meridian Bioscience.